logo
  • Home
  • About Us
    • Overview
    • Objectives
    • Patients
  • Research
    • Overview
    • Projects
    • Trials
    • Publications
  • People
    • At the Centre
    • Research Team
    • Clinical Team
    • Post-docs & Trainees
    • Affiliates
    • Engagement
  • News
    • Recent News
    • About Our Events
    • Upcoming Events
    • Past Events
    • News Archive
    • Seminars & Podcasts
  • Support
    • Supporting Us
    • Support For You
  • Contact Us

News: Archive

  • May 2023

Programme member elected to the Academy of Medical Sciences Fellowship. Professor Serena Nik-Zainal is NIHR Research Professor and Professor of Genomic Medicine and Bioinformatics in the Department of Medical Genetics and Early Cancer Institute. As an expert in studying ‘mutational signatures’, Serena is involved in the PRICKLE study, which is a single-centre, non-randomised phase 2a clinical trial investigating the feasibility of downstaging borderline unresectable pancreatic cancer.

Read More
  • May 2023

Members attending London Pancreas Workshop win poster awards | CRUK CC

Learn More
  • April 2023

Our research team members - Giulia Biffi, Tony Coll and Steve O'Rahilly - co-authoured the review article "Cachexia: A systemic consequence of progressive, unresolved disease" published on Cell.

Read more about the paper
  • February 2023

Our clinical team published results of SIEGE trial on British Journal of Cancer. SIEGE trial is a randomised phase 2 study aiming to see whether sequential administration of nab-paclitaxel + gemcitabine 24 h apart could improve outcomes in patients with metastatic PDAC compared to standard delivery of 2 drugs on the same day

Read more about the paper
  • February 2022

Webinar: Ask me anything about… keeping fit with pancreatic cancer

Learn More
  • January 2022

Programme members appear on BBC News

Learn More
  • November 2021

Giulia Biffi receives funding award from PCRF

Learn More
  • November 2021

Programme members and associates participate in a webinar (Ask me anything about pancreatic cancer) on World Pancreatic Cancer Day 2021

Learn More
  • November 2021

Programme members raise awareness of pancreatic cancer and its symptoms on World Pancreatic Cancer Day 2021

Learn More
  • November 2021

Fundraising by the Biffi lab on World Pancreatic Cancer Day 2021

Learn More
  • October 2021

Two further students begin their PhD projects to investigate PDAC

Learn More
  • September 2021

Fundraising for the CPCC by residents of Exning, Newmarket Learn More

  • August 2021

Charity event in Exning raises money for the Cambridge Pancreatic Cancer Centre

Learn More
  • August 2021

Dr Serena Nik-Zainal awarded the Francis Crick Medal and Lecture 2022.

Learn More
  • August 2021

Prof Stephen O’Rahilly awarded the 2022 Croonian Medal of The Royal Society.

Learn More
  • July 2021

Jill Barker receives CUH ‘You Made a Difference’ Award for the second time

Learn More
  • June 2021

Team CANCAN, including Dr Giulia Biffi and Prof Stephen O’Rahilly, has been shortlisted for a Cancer Grand Challenge award.

Learn More
  • April 2021

Cambridge Pancreatic Cancer Centre awarded a £625,000 grant by Pancreatic Cancer UK to improve understanding of tumour-stromal and tumour-immune interactions in pancreatic ductal adenocarcinoma (PDAC)

Learn More
  • May 2021

Dr Bristi Basu to take over as Programme Co-Lead from Professor Duncan Jodrell

Learn More
  • May 2021
  • Programme member, Professor Adrian Liston, appointed as a Fellow in the Academy of Medical Sciences.

    Learn More

Mr. Siong-Seng Liau, Honorary Senior Clinician Scientist Fellow and Academic Consultant Hepatobiliary and Pancreatic Surgeon, has been awarded a Pancreatic Cancer UK Research Innovation Fund. Mr Liau has been awarded £108,000 over 2 years for his project, “Strengthening the immune system’s ability to fight pancreatic cancer”

Learn More

Researchers from the CPCC are part of a Stand Up To Cancer – Lustgarten Foundation Dream

Learn More

Researchers from the CPCC have identified a new pathway by which gemcitabine is broken down in tumour cells

Learn More

News and Events

  • Recent News
  • About Our Events
  • Upcoming Events
  • Past Events
  • News Archive
  • Seminars & Podcasts
©2022 University of Cambridge